Recent Advances in Understanding Cholangiocarcinoma [version 1; referees: 2 approved]
Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, cholangiocytes, and possibly de-differentiated hepatocytes. CCA has a poor overall survival rate and limited therapeutic options. Based on this data, it is imperative that new diagnostic and therapeutic i...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-10-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-1818/v1 |